Brut benzene deodorants

In November 2021, Valisure's research uncovered extensive benzene contamination across a broad range of aerosol deodorants and antiperspirants from market-leading US manufacturers. After testing 108 batches of products from 30 separate brands, benzene was found in more than half of the samples in varying concentrations. Two sets of Brut brand antiperspirants were found to be contaminated. Benzene is a class 1 solvent and carcinogen with no safe level of exposure that is clinically known to cause multiple types of cancers, including leukemia. While the FDA tolerates minuscule amounts of benzene (2ppm) in certain drugs for therapeutic advancement purposes, no amounts of benzene are allowed in personal hygiene products like deodorants.

Claim Application

Testing results

Valisure's report indicated that two batches of a Brut brand antiperspirant showed signs of benzene contamination, with one batch containing more than double the amount of acceptable FDA standards.

  • Brut Classic, 24 Hr Protection – 4.13ppm/2.34ppm

While benzene contamination was detected, it isn't one of the ingredients manufacturers use. It is most probably the result of propellants used in aerosol sprays like propane, butane, isobutane, alcohol, and hydrofluorocarbon 152a.

Recalled Brut deodorants

After benzene contamination became publicly known, outraged consumers started filing class action complaints against the culpable manufacturers. In February 2022, HRB Brands voluntarily recalled a range of contaminated deodorants and antiperspirants, including 4 Brut brand products

  • Brut – Classic Antiperspirant Aerosol, 4oz
  • Brut – Classic Antiperspirant Aerosol, 6oz
  • Brut – Classic Deodorant Aerosol, 154g
  • Brut – Classic Deodorant Aerosol, 10oz

File your benzene deodorant claim with Environmental Litigation Group

Environmental Litigation Group's team of skilled attorneys and legal experts has assisted clients injured by unsafe products for over 30 years. If you believe that your regular use of benzene deodorants is responsible for your acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), or chronic lymphocytic leukemia (CLL) diagnosis, we can determine your claim's eligibility and the appropriate compensation you are owed.

We will only require that you provide us with the details surrounding your use of benzene deodorants and medical records that confirm your diagnosis. This will allow us to handle the time-consuming legal aspects on your behalf, providing you more time to focus on your health.